Back to Search
Start Over
Synergistic effects of carboxymethyl-hexanoyl chitosan, cationic polyurethane-short branch PEI in miR122 gene delivery: accelerated differentiation of iPSCs into mature hepatocyte-like cells and improved stem cell therapy in a hepatic failure model.
- Source :
-
Acta biomaterialia [Acta Biomater] 2015 Feb; Vol. 13, pp. 228-44. Date of Electronic Publication: 2014 Nov 21. - Publication Year :
- 2015
-
Abstract
- MicroRNA122 (miR122), a liver-specific microRNA, plays critical roles in homeostatic regulation and hepatic-specific differentiation. Induced pluripotent stem cells (iPSCs) have promising potential in regenerative medicine, but it remains unknown whether non-viral vector-mediated miR122 delivery can enhance the differentiation of iPSCs into hepatocyte-like cells (iPSC-Heps) and rescue thioacetamide-induced acute hepatic failure (AHF) in vivo. In this study, we demonstrated that embedment of miR122 complexed with polyurethane-graft-short-branch polyethylenimine copolymer (PU-PEI) in nanostructured amphiphatic carboxymethyl-hexanoyl chitosan (CHC) led to dramatically enhanced miR122 delivery into human dental pulp-derived iPSCs (DP-iPSCs) and facilitated these DP-iPSCs to differentiate into iPSC-Heps (miR122-iPSC-Heps) with mature hepatocyte functions. Microarray and bioinformatics analysis further indicated that CHC/PU-PEI-miR122 promoted the gene-signature pattern of DP-iPSCs to shift into a liver-specific pattern. Furthermore, intrahepatic delivery of miR122-iPSC-Heps, but not miR-Scr-iPSC-Heps, improved liver functions and rescued recipient survival, and CHC-mediated delivery showed a better efficacy than that using phosphate buffered saline as a delivery vehicle. In addition, these transplanted miR122-iPSC-Heps remained viable and could produce circulatory albumin for 4 months. Taken together, our findings demonstrate that non-viral delivery of miR122 shortens the time of iPSC differentiation into hepatocytes and the delivery of miR122-iPSC-Heps using CHC as a vehicle exhibited promising hepatoprotective efficacy in vivo. miR122-iPSC-Heps may represent a feasible cell source and provide an efficient and alternative strategy for hepatic regeneration in AHF.<br /> (Copyright © 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.)
- Subjects :
- Animals
Chitosan pharmacology
Disease Models, Animal
Heterografts
Humans
Liver Failure genetics
Liver Failure metabolism
Liver Failure pathology
Male
Mice
Mice, Inbred BALB C
Mice, Nude
Cell Differentiation drug effects
Cell Differentiation genetics
Chitosan analogs & derivatives
Gene Transfer Techniques
Hepatocytes metabolism
Hepatocytes transplantation
Induced Pluripotent Stem Cells metabolism
Liver Failure therapy
MicroRNAs biosynthesis
MicroRNAs genetics
Polyurethanes pharmacology
Subjects
Details
- Language :
- English
- ISSN :
- 1878-7568
- Volume :
- 13
- Database :
- MEDLINE
- Journal :
- Acta biomaterialia
- Publication Type :
- Academic Journal
- Accession number :
- 25463491
- Full Text :
- https://doi.org/10.1016/j.actbio.2014.11.018